Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia

<p>Abstract</p> <p>Background</p> <p>The social and medical impact of rare diseases is increasingly recognized. Amyotrophic lateral sclerosis (ALS) is the most prevalent of the motor neuron diseases. It is characterized by rapidly progressive damage to the motor neurons...

Full description

Bibliographic Details
Main Authors: Nagel Gabriele, Ünal Hatice, Rosenbohm Angela, Ludolph Albert C, Rothenbacher Dietrich
Format: Article
Language:English
Published: BMC 2013-02-01
Series:BMC Neurology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2377/13/22
id doaj-6c60f0d3f619404591bd3298e97798ae
record_format Article
spelling doaj-6c60f0d3f619404591bd3298e97798ae2020-11-24T23:28:20ZengBMCBMC Neurology1471-23772013-02-011312210.1186/1471-2377-13-22Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry SwabiaNagel GabrieleÜnal HaticeRosenbohm AngelaLudolph Albert CRothenbacher Dietrich<p>Abstract</p> <p>Background</p> <p>The social and medical impact of rare diseases is increasingly recognized. Amyotrophic lateral sclerosis (ALS) is the most prevalent of the motor neuron diseases. It is characterized by rapidly progressive damage to the motor neurons with a survival of 2–5 years for the majority of patients. The objective of this work is to describe the study protocol and the implementation steps of the amyotrophic lateral sclerosis (ALS) registry Swabia, located in the South of Germany.</p> <p>Methods/Design</p> <p>The ALS registry Swabia started in October 2010 with both, the retrospective (01.10.2008-30.09.2010) and prospective (from 01.10.2010) collection of ALS cases, in a target population of 8.6 million persons in Southern Germany. In addition, a population based case–control study was implemented based on the registry that also included the collection of various biological materials.</p> <p>Retrospectively, 420 patients (222 men and 198 women) were identified. Prospectively data of ALS patients were collected, of which about 70% agreed to participate in the population-based case–control study. All participants in the case–control study provided also a blood sample. The prospective part of the study is ongoing.</p> <p>Discussion</p> <p>The ALS registry Swabia has been implemented successfully. In rare diseases such as ALS, the collaboration of registries, the comparison with external samples and biorepositories will facilitate to identify risk factors and to further explore the potential underlying pathophysiological mechanisms.</p> http://www.biomedcentral.com/1471-2377/13/22Amyotrophic lateral sclerosisRegistryRisk factors
collection DOAJ
language English
format Article
sources DOAJ
author Nagel Gabriele
Ünal Hatice
Rosenbohm Angela
Ludolph Albert C
Rothenbacher Dietrich
spellingShingle Nagel Gabriele
Ünal Hatice
Rosenbohm Angela
Ludolph Albert C
Rothenbacher Dietrich
Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
BMC Neurology
Amyotrophic lateral sclerosis
Registry
Risk factors
author_facet Nagel Gabriele
Ünal Hatice
Rosenbohm Angela
Ludolph Albert C
Rothenbacher Dietrich
author_sort Nagel Gabriele
title Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
title_short Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
title_full Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
title_fullStr Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
title_full_unstemmed Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
title_sort implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (als) - registry swabia
publisher BMC
series BMC Neurology
issn 1471-2377
publishDate 2013-02-01
description <p>Abstract</p> <p>Background</p> <p>The social and medical impact of rare diseases is increasingly recognized. Amyotrophic lateral sclerosis (ALS) is the most prevalent of the motor neuron diseases. It is characterized by rapidly progressive damage to the motor neurons with a survival of 2–5 years for the majority of patients. The objective of this work is to describe the study protocol and the implementation steps of the amyotrophic lateral sclerosis (ALS) registry Swabia, located in the South of Germany.</p> <p>Methods/Design</p> <p>The ALS registry Swabia started in October 2010 with both, the retrospective (01.10.2008-30.09.2010) and prospective (from 01.10.2010) collection of ALS cases, in a target population of 8.6 million persons in Southern Germany. In addition, a population based case–control study was implemented based on the registry that also included the collection of various biological materials.</p> <p>Retrospectively, 420 patients (222 men and 198 women) were identified. Prospectively data of ALS patients were collected, of which about 70% agreed to participate in the population-based case–control study. All participants in the case–control study provided also a blood sample. The prospective part of the study is ongoing.</p> <p>Discussion</p> <p>The ALS registry Swabia has been implemented successfully. In rare diseases such as ALS, the collaboration of registries, the comparison with external samples and biorepositories will facilitate to identify risk factors and to further explore the potential underlying pathophysiological mechanisms.</p>
topic Amyotrophic lateral sclerosis
Registry
Risk factors
url http://www.biomedcentral.com/1471-2377/13/22
work_keys_str_mv AT nagelgabriele implementationofapopulationbasedepidemiologicalrarediseaseregistrystudyprotocoloftheamyotrophiclateralsclerosisalsregistryswabia
AT unalhatice implementationofapopulationbasedepidemiologicalrarediseaseregistrystudyprotocoloftheamyotrophiclateralsclerosisalsregistryswabia
AT rosenbohmangela implementationofapopulationbasedepidemiologicalrarediseaseregistrystudyprotocoloftheamyotrophiclateralsclerosisalsregistryswabia
AT ludolphalbertc implementationofapopulationbasedepidemiologicalrarediseaseregistrystudyprotocoloftheamyotrophiclateralsclerosisalsregistryswabia
AT rothenbacherdietrich implementationofapopulationbasedepidemiologicalrarediseaseregistrystudyprotocoloftheamyotrophiclateralsclerosisalsregistryswabia
_version_ 1725549588507525120